AbbVie Skyrizi captures 7.5% share of pharma streaming ad impressions
A report from iSpot.tv and Tubular Labs highlights that pharmaceutical brands are heavily concentrating ad spend on CTV and news programming, while telehealth brands are increasingly leveraging YouTube Shorts for high-volume engagement. The data indicates a shift in media strategy as pharma advertisers balance traditional linear reach with digital-first social video platforms.
Key Takeaways
- Prescription brands claimed nine of the top 10 spots for streaming impressions share of voice in July.
- AbbVie spent $29.3 million on Skyrizi advertising during the month, the highest total of any brand tracked.
- BlueChew generated 397 million YouTube views, utilizing YouTube Shorts for 16 of its 24 monthly uploads.
- ABC led all networks for pharma linear TV reach with a 10.49% impressions share of voice.
Why It Matters
The concentration of prescription drug advertising on streaming platforms indicates a strategic shift toward high-value, targeted digital environments that mirror traditional linear news reach. As immunology brands like Skyrizi and Tremfya outspend over-the-counter competitors by tens of millions, the streaming ecosystem is becoming a critical battleground for high-margin pharmaceutical products. This trend forces ad-supported platforms to balance medical content regulations with the lucrative demand for older, affluent viewer demographics. Watch for whether the 15.35% year-over-year growth in pharma impressions on Fox News translates into similar aggressive spending increases on right-leaning streaming news alternatives.
Additional Context
As US CTV ad spend continues to climb, pharmaceutical brands are increasingly leveraging the precision of programmatic advertising platforms to reach specific patient cohorts, a trend that programmatic competition intensifies as major players scale their operations.
Read full article at mmm-online.com
Enjoy our coverage?
Add StreamingMeme as a preferred source on Google to see more of our streaming news at the top of your Search results.
Add as preferred source